The impact of PI3K/AKT inhibitor on the radiosensitization of breast cancer cells

被引：0
|
作者：
Fu, S
Zeng, QW
Sun, Y
Zhang, Q
Shao, YH
Jian, GL
机构：
[1] Jiao Tong Univ, Shanghai Hosp 6, Shanghai 200233, Peoples R China
[2] Fudan Univ, Shanghai Canc Hosp, Shanghai 200032, Peoples R China
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 78卷
关键词：
breast cancer; Ly294002; PI3K; AKT; radiotherapy;
D O I：
10.1016/S0167-8140(06)80740-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
263
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [21] PI3K signaling in cancer: beyond AKT
    Lien, Evan C.
    Dibble, Christian C.
    Toker, Alex
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2017, 45 : 62 - 71
  • [22] PI3K and AKT: Unfaithful Partners in Cancer
    Faes, Seraina
    Dormond, Olivier
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (09): : 21138 - 21152
  • [23] PI3K/Akt signalling pathway and cancer
    Vara, JAF
    Casado, E
    de Castro, J
    Cejas, P
    Belda-Iniesta, C
    González-Barón, M
    [J]. CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
  • [24] Divergent activation of AKT1 and AKT2 isoforms downstream of PI3K mutation impacts response of breast cancer cells to estradiol and PI3K inhibitors
    Nakshatri, Harikrishna
    Goswami, Chirayu
    Badve, Sunil
    Magnani, Luca
    Lupien, Mathieu
    Bhat-Nakshatri, Poornima
    [J]. CANCER RESEARCH, 2015, 75
  • [25] The Impact of PI3K Inhibitors for the Treatment of Patients with Breast Cancer
    Traina, Tiffany A.
    [J]. ONCOLOGY-NEW YORK, 2020, 34 (01): : 28 - 31
  • [26] PI3K/Akt/mTOR signaling pathway in cancer stem cells
    Fath, Mohsen Karami
    Ebrahimi, Menooa
    Nourbakhsh, Ehsan
    Hazara, Ahmad Zia
    Mirzaei, Ali
    Shafieyari, Saba
    Salehi, Azadeh
    Hoseinzadeh, Mahsa
    Payandeh, Zahra
    Barati, Ghasem
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
  • [27] IMAGING CAN IDENTIFY PI3Kα-INHIBITOR SUSCEPTIBILITY IN BREAST CANCER
    不详
    [J]. CANCER DISCOVERY, 2020, 10 (12) : 1786 - 1786
  • [28] Lactate Lights up PI3K Inhibitor Resistance in Breast Cancer
    Hillis, Alissandra L.
    Toker, Alex
    [J]. CANCER CELL, 2020, 38 (04) : 441 - 443
  • [29] The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
    Paplomata, Elisavet
    O'Regan, Ruth
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2014, 6 (04) : 154 - 166
  • [30] Novel tumor suppressor regulating the PI3K/AKT pathway in breast cancer
    Chan, Stefanie
    Cardamone, M. Dafne
    Perissi, Valentina
    [J]. CANCER RESEARCH, 2018, 78 (04)
12345